Skip to content

News

Ovarian Cancer Endpoints Workshop hosted by the Food and Dr...

Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA)

By Annie Ellis On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA).  This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the … Continued

#30DaysofTeal: Day 30

#30DaysofTeal: Day 30

This #30DaysofTeal, you helped us give ovarian cancer the spotlight over 1 million times-THANK YOU! But #30DaysofTeal doesn’t stop today…We Teal year round for the everyone affected by ovarian cancer, so keep spreading awareness and the Teal love.

#30DaysofTeal: Day 29

#30DaysofTeal: Day 29

Today we are excited to announce the creation of the Congressional Ovarian Cancer Caucus, a group of lawmakers in Washington, DC committed to advancing awareness and research in ovarian cancer. Please help us build this important movement and ask your Member of Congress to join the Caucus today. http://cqrcengage.com/ovarian/app/write-a-letter?7&engagementId=130619

#30DaysofTeal: Day 28

#30DaysofTeal: Day 28

Family history also contributes to a woman’s risk of ovarian cancer. Women who have one first-degree relative with ovarian cancer but no known genetic mutation still have an increased risk of developing ovarian cancer.  The lifetime risk of a woman who has a first degree relative with ovarian cancer is five percent (the average woman’s … Continued

#30DaysofTeal: Day 27

#30DaysofTeal: Day 27

Today marks the start of National Hereditary Breast and Ovarian Cancer Week and we’re encouraging all women to learn their risk for Hereditary Breast and Ovarian Cancer. Did you know these two diseases are linked, especially for women with mutations in the BRCA1 and BRCA2 genes. Not sure if you might have a mutation? The … Continued

#30DaysofTeal: Day 26

#30DaysofTeal: Day 26

All month long we have been celebrating caregivers in our community. Today we are sharing the story of Donella and her mom Dorothey. Dorothey was experiencing the symptoms of ovarian cancer and her general doctor advised to limit her salt intake. Donella, took action and became an advocate for her mom, researching her symptoms and … Continued

#30DaysofTeal: Day 25

#30DaysofTeal: Day 25

The National Comprehensive Cancer Network Guidelines for Ovarian Cancer can help walk you through all aspects of an ovarian cancer diagnosis. It answers questions from before a diagnosis through the whole cancer care continuum. You can use this guide as a way to learn more and go back to your doctor with questions you might … Continued

#30DaysofTeal: Day 24

#30DaysofTeal: Day 24

Are you interested in making a difference in the lives of women with ovarian cancer? Become an Advocate Leader in 2016! Our Advocate Leaders are a group of highly trained individuals who advance the interests of women with ovarian cancer at the local, state and federal levels. The Advocate Leaders have raised awareness through news … Continued

#30DaysofTeal: Day 23

#30DaysofTeal: Day 23

The past few years have seen significant changes to healthcare across the United States with the implementation of the Affordable Care Act, including some great progress made for women at risk of and with ovarian cancer. While we have made good strides in state policies, there is still a lot of work to be done. … Continued

#30DaysofTeal: Day 22

#30DaysofTeal: Day 22

Are you ready to look for a clinical trial? The Ovarian Cancer National Alliance offers a Clinical Trials Matching Service in partnership with Carebox. This one-stop service provides a comprehensive yet simplified system for women to find and link to clinical trial options for ovarian cancer. Find a clinical trial that’s right for you at … Continued

Small Trial Shows Promising Results for Nivolumab in Ovaria...

Small Trial Shows Promising Results for Nivolumab in Ovarian Cancer

(September 21, 2015) A small study found that treatment with the anti-PD-1 immunotherapy nivolumab was able to produce complete responses in patients with advanced platinum-resistant ovarian cancer. The phase II study of 20 patients had an overall response rate of 15% (3 responders); an additional 6 patients had stable disease. The median progression-free survival time … Continued

#30DaysofTeal: Day 21

#30DaysofTeal: Day 21

Tickets are now available for the 2016 Turn Up the Heat! Gala in Washington DC. Turn Up the Heat features food from the top female chefs in DC and the surrounding area! Join us on February 17th for a night full of delicious food and great company. Get your tickets at www.ovariancancer.org/dcgala Get your tickets … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.